SkinDermic® is a drug discovery company focused on developing breakthrough and innovative small molecule drugs for the treatment of HHV8 virus linked neoplasia and inflammatory skin diseases. SkinDermic® recently completed proof of concept clinical phase in humans with its First-in-Class treatments for acne and HHV8 associated diseases (Kaposi Sarcoma and Lymphomas). Skindermic owns now a pipeline with very active and very well tolerated new drugs for HHV8 associated diseases and acne vulgaris.
| Website | http://skindermic.com |
| Employees | 5 (0 on RocketReach) |
| Founded | 2017 |
| Address | 24 Rue Du Faubourg Saint Jacques, Paris, Ile de France 75014, FR |
| Technologies |
JavaScript
,
HTML
,
PHP
+4 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Keywords | Drug Discovery, Dermatology, Small Molecule Drugs, Drug Development, Skin Disease Treatment, Pharmaceutical Research, Innovative Medicines, Antiviral Drugs, Biotechnology, Viral Diseases, Therapeutic Innovation, Molecular Medicine, Oncology, Clinical Trials, New Drugs, Proof Of Concept |
| Competitors | Dermalogica, Obagi, Murad, Kiehl's USA, SkinCeuticals, Cerave, DECIEM | THE ABNORMAL BEAUTY COMPANY, Neutrogena, La Roche-Posay Laboratoire Dermatologique, Clinique +38 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular SkinDermic employee's phone or email?
SkinDermic Questions
SkinDermic is based in Paris, Ile de France.
The NAICS codes for SkinDermic are [32, 3254, 325, 32541].
The SIC codes for SkinDermic are [28, 283, 2834].
Related Companies
